Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma (clinicaltrials.gov) - Oct 3, 2026 - P1 | N=31 | Suspended | Sponsor: City of Hope Medical Center | Active, not recruiting ➔ Suspended
Trial suspension • Clear Cell Renal Cell Carcinoma • Genito-urinary Cancer • Oncology • Renal Cell Carcinoma • Sarcoma • Solid Tumor
|